Following this, we analyzed the transcription levels of DDIT4 based on the stages of breast cancer, patient gender, age, primary subtypes, major subclasses with TNBC, menopausal status, nodal metastasis status, and TP53 mutation status. This evidence concerns the gene TP53 and breast carcinoma.